Knobbe Martens

2040 Main Street
14th Floor
Irvine, CA 92614, United States
Phone: (949) 760-0404
Fax: (949) 760-9502
Areas of Practice
  • Intellectual Property
  • Litigation
Other U.S. Locations
  • California
  • D.C.
  • New York
  • Washington
Number of Attorneys
100+ Attorneys

Simpleair, Inc. v. Google, LLC.

Federal Circuit Summaries - Before Lourie, Reyna, and Chen. Appeal from the U.S. District Court for the Eastern District of Texas, Judge J. Rodney Gilstrap. Summary: Filing a terminal disclaimer to overcome an…more
 /  Civil Procedure, Intellectual Property

Jury’s Award for Patent Infringement Increased to 3 Million for Infringing Window Blinds Components

Patent Judgments & Awards - On February 8, 2018, Judge Andrew Guilford of the District Court for Central District of California increased a jury award against Custom Blinds and Components Inc. (“CBC”) for patent infringement…more
 /  Civil Remedies, Intellectual Property

Vintage or Protectable? Steve Madden Creates Waves for the Ark

Jasmin Larian, the owner of Cult Gaia, started selling the “Ark” bag in 2013. Since then the Ark bag has been seen on celebrities including Jessica Alba and was even touted as 2017’s “IT” bag…more
 /  Civil Procedure, Civil Remedies, Communications & Media Law, Intellectual Property

Federal Circuit Review - February 2018

Improperly Drafted Employment Agreement Leads to Dismissal of Patent Case Due to Lack of Standing - In Advanced Video Technologies LLC v. HTC Corporation et al., Appeal Nos. 2016-2309, 2016-2310, 2016-2311, the Federal…more
 /  Administrative Law, Civil Procedure, Constitutional Law, Intellectual Property, Science, Computers, & Technology

PTAB holds Genentech’s antibody purification method claims unpatentable as anticipated and obvious

The PTAB held that all of Genentech’s challenged antibody purification claims were unpatentable as being anticipated, obvious, or both, in an IPR filed by Hospira and Pfizer, Hospira, Inc., v. Genentech, Inc., IPR2016-01837,…more
 /  Administrative Law, Intellectual Property, Science, Computers, & Technology

PTAB Grants Motion to Amend After Aqua Products

In Polygroup Limited v. Willis Electric Co., Ltd., IPR2016-01613, Paper 118 (Feb. 26, 2018), the PTAB granted the patent owner Willis Electric’s motion to amend a claim directed to lighted artificial trees. This decision follows…more
 /  Administrative Law, Intellectual Property

Johnson & Johnson Acquires French Surgical Tech Firm Orthotaxy

On February 20, 2018, Johnson & Johnson Medical Devices Companies announced the acquisition of Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery…more
 /  Intellectual Property, Mergers & Acquisitions, Science, Computers, & Technology

Ottah v. Fiat Chrysler

Federal Circuit Summaries - Before Newman, Hughes, and Stoll. Appeal from U.S. District Court for the Southern District of New York. Summary: General disclosures in the specification and statements that describe the…more
 /  Civil Procedure, Intellectual Property

The Saint Regis Mohawk Tribe is not entitled to Sovereign Immunity at the PTAB

The PTAB dismissed the Saint Regis Mohawk Tribe’s attempt to avoid IPR of patents covering Restasis®, which Allergan transferred to the Tribe in a highly publicized patent deal. See Allergan and the Saint Regis Mohawk Tribe…more
 /  Administrative Law, Civil Procedure, Indigenous Peoples, Intellectual Property, Science, Computers, & Technology

Sovereign Immunity at the PTAB: Where do we stand?

Sovereign Immunity - Sovereign immunity exempts a sovereign from the jurisdiction of a court - States are entitled to sovereign immunity under the 11th amendment Seminole Tribe of Fla v. Florida, 517 U.S. 44 (1996) …more
 /  Administrative Law, Constitutional Law, Education, Indigenous Peoples, Intellectual Property

Improper Markush Rejection: The New Kid on the Patent Block

The U.S. Patent and Trademark Office (“USPTO”) quietly increased the examiners’ arsenal by slipping a new rejection into the latest revision of the Manual of Patent Examining Procedure (“MPEP”) released last month. One of the…more
 /  Administrative Law, Intellectual Property

Xeris' Pharmaceuticals Glucagon Progresses Towards FDA Approval

Xeris Pharmaceuticals, Inc. (“Xeris”) recently announced successful completion of both adult and pediatric clinical studies for its glucagon rescue pen...…more
 /  Health, Science, Computers, & Technology

Janssen’s Erleada Will be the First Participant in FDA’s Clinical Data Summary Pilot Program

On February 14, 2018, the U.S. Food and Drug Administration (FDA) approved Janssen Therapeutics’ Erleada (apalutamide), a non-steroidal antiandrogen for the treatment of castration-resistant non-metastatic prostate cancer...…more
 /  Health, Science, Computers, & Technology

U.S. to Have its Own Supply of the Most Commonly Used Medical Imaging Isotope for the First Time in 30 Years

Medical imaging isotopes are used to diagnose various diseases, such as cancer and coronary artery disease, and to evaluate brain, lung, kidney, and liver function. According to an U.S. Food and Drug Administration (FDA) press…more
 /  Health, Science, Computers, & Technology

FDA Clears New Surgery Infection Control System

The FDA recently cleared Prescient Surgical’s CleanCisionTM Wound Retraction and Protection System (CleanCisionTM), a retractable device designed to prevent surgical site infection. According to Prescient Surgical,…more
 /  Health, Science, Computers, & Technology
Showing 1-15 of 841 Results
View per page
Page: of 57
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.